The binding of sickle hemoglobin to the cytoplasmic domain of protein 3 is emerging as a central interaction in the pathogenesis of membrane damage in sickle cell disease. This interaction targets toxic iron species to vulnerable membrane proteins and ultimately causes protein 3 to cluster, a rearrangement that also involves ankyrin and glycophorin. At the outer surface of the cell, the clustered proteins are recognized by autoantibodies in the plasma and become decorated with immunoglobulin and complement. This signal incites macrophages to remove the cells prematurely from circulation. Additional potential effects of this interaction include clustering of other membrane proteins, modulation of cellular metabolism, and alteration of important structural membrane protein-protein interactions. Our hypothesis is that the composition of the cytoplasmic domain of protein 3 is an important variable in this pivotal interaction, and has an impact on the pathophysiology of sickle cell disease. We will use three experimental systems to study the influences of a variety of cytoplasmic domain structures. 1) We will use a system we design to test protein-3 hemoglobin interactions by measuring the influence of cytoplasmic domain of protein 3 on the hemoglobin dimer- tetramer equilibrium. We will test purified native cytoplasmic domain of protein 3 as well as specifically-designed mutant peptides to map the key residues on both the hemoglobin and protein 3 side of the interaction. 2) We have found an unexpectedly high prevalence of a cytoplasmic domain of protein 3 mutant (Memphis, 56-->GLU) in sickle cell anemia and hypothesize that its presence increases disease severity. We will define the impact of this mutation on biochemistry, physiology, hematology, and clinical severity. 3) The cytoplasmic domain of protein 3 is poorly conserved in mice, and we hypothesize that its interaction with human sickle hemoglobin will be reduced, limiting the comparability of the mouse model. We will compare the physiologic, biochemical, and clinical phenotype to the conventional mouse model.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL015157-28
Application #
6109383
Study Section
Project Start
1999-04-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
28
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Loscalzo, Joseph (2012) Irreproducible experimental results: causes, (mis)interpretations, and consequences. Circulation 125:1211-4
Steinberg, Martin H; Sebastiani, Paola (2012) Genetic modifiers of sickle cell disease. Am J Hematol 87:795-803
Vandorpe, David H; Xu, Chang; Shmukler, Boris E et al. (2010) Hypoxia activates a Ca2+-permeable cation conductance sensitive to carbon monoxide and to GsMTx-4 in human and mouse sickle erythrocytes. PLoS One 5:e8732
Jahangir, Eiman; Vita, Joseph A; Handy, Diane et al. (2009) The effect of L-arginine and creatine on vascular function and homocysteine metabolism. Vasc Med 14:239-48
Casula, Sabina; Zolotarev, Alexander S; Stuart-Tilley, Alan K et al. (2009) Chemical crosslinking studies with the mouse Kcc1 K-Cl cotransporter. Blood Cells Mol Dis 42:233-40
Steinberg, Martin H; Voskaridou, Ersi; Kutlar, Abdullah et al. (2003) Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease. Am J Hematol 72:121-6
Ware, Russell E; Eggleston, Barry; Redding-Lallinger, Rupa et al. (2002) Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood 99:10-4
Mirchev, R; Golan, D E (2001) Single-particle tracking and laser optical tweezers studies of the dynamics of individual protein molecules in membranes of intact human and mouse red cells. Blood Cells Mol Dis 27:143-7
Jiang, L; Jha, V; Dhanabal, M et al. (2001) Intracellular Ca(2+) signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin. Am J Physiol Cell Physiol 280:C1140-50
Shmukler, B E; Brugnara, C; Alper, S L (2000) Structure and genetic polymorphism of the mouse KCC1 gene. Biochim Biophys Acta 1492:353-61

Showing the most recent 10 out of 39 publications